Company registration number 08282831 (England and Wales)
CENTRAL MUSCULOSKELETAL IMAGING LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
CENTRAL MUSCULOSKELETAL IMAGING LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
CENTRAL MUSCULOSKELETAL IMAGING LTD
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1
751
Investments
5
388,617
298,333
388,618
299,084
Current assets
Debtors
6
14,317
12,238
Cash at bank and in hand
230,140
179,368
244,457
191,606
Creditors: amounts falling due within one year
7
(149,631)
(134,131)
Net current assets
94,826
57,475
Net assets
483,444
356,559
Capital and reserves
Called up share capital
100
100
Revaluation reserve
8
3,242
3,242
Profit and loss reserves
480,102
353,217
Total equity
483,444
356,559

The notes on pages 2 to 6 form part of these financial statements.

For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 6 August 2026 and are signed on its behalf by:
Dr C S J Fang
Director
Company registration number 08282831 (England and Wales)
CENTRAL MUSCULOSKELETAL IMAGING LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 2 -
1
Accounting policies
Company information

Central Musculoskeletal Imaging Ltd is a private company limited by shares incorporated in England and Wales. The registered office is c/o SAL 94 West Parade, Lincoln, LN1 1JZ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

The company recognises revenue from the following major sources:

- medical consultancy

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% Reducing balance
Computer equipment
33% Straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

CENTRAL MUSCULOSKELETAL IMAGING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 3 -

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

CENTRAL MUSCULOSKELETAL IMAGING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
CENTRAL MUSCULOSKELETAL IMAGING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 5 -
4
Tangible fixed assets
Fixtures and fittings
Computer equipment
Total
£
£
£
Cost
At 1 December 2024 and 30 November 2025
766
8,742
9,508
Depreciation and impairment
At 1 December 2024
766
7,990
8,756
Depreciation charged in the year
-
0
751
751
At 30 November 2025
766
8,741
9,507
Carrying amount
At 30 November 2025
-
0
1
1
At 30 November 2024
-
0
751
751
5
Fixed asset investments
2025
2024
£
£
Other investments other than loans
388,617
298,333
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 December 2024
298,333
Additions
90,284
At 30 November 2025
388,617
Carrying amount
At 30 November 2025
388,617
At 30 November 2024
298,333
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
14,317
12,238
CENTRAL MUSCULOSKELETAL IMAGING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 6 -
7
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
33,749
25,160
Other taxation and social security
-
0
960
Other creditors
115,882
108,011
149,631
134,131
8
Revaluation reserve
2025
2024
£
£
At the beginning and end of the year
3,242
3,242
9
Fair value reserve
2025
2024
£
£
At the beginning and end of the year
-
-
2025-11-30 2024-12-01 false false false 06 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Dr C S J Fang Mrs J Fang 08282831 2024-12-01 2025-11-30 08282831 2025-11-30 08282831 2024-11-30 08282831 core:FurnitureFittings 2025-11-30 08282831 core:ComputerEquipment 2025-11-30 08282831 core:FurnitureFittings 2024-11-30 08282831 core:ComputerEquipment 2024-11-30 08282831 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 08282831 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 08282831 core:CurrentFinancialInstruments 2025-11-30 08282831 core:CurrentFinancialInstruments 2024-11-30 08282831 core:ShareCapital 2025-11-30 08282831 core:ShareCapital 2024-11-30 08282831 core:RevaluationReserve 2025-11-30 08282831 core:RevaluationReserve 2024-11-30 08282831 core:RetainedEarningsAccumulatedLosses 2025-11-30 08282831 core:RetainedEarningsAccumulatedLosses 2024-11-30 08282831 bus:Director1 2024-12-01 2025-11-30 08282831 core:FurnitureFittings 2024-12-01 2025-11-30 08282831 core:ComputerEquipment 2024-12-01 2025-11-30 08282831 2023-12-01 2024-11-30 08282831 core:FurnitureFittings 2024-11-30 08282831 core:ComputerEquipment 2024-11-30 08282831 2024-11-30 08282831 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 08282831 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 08282831 bus:FRS102 2024-12-01 2025-11-30 08282831 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 08282831 bus:Director2 2024-12-01 2025-11-30 08282831 bus:FullAccounts 2024-12-01 2025-11-30 xbrli:pure xbrli:shares iso4217:GBP